Exhibit 99.1
| | | | |
| | Contact: | | Charles Lambert |
| | | | Finance Director |
| | | | Medical Properties Trust |
| | | | (205) 397-8897 |
| | | | clambert@medicalpropertiestrust.com |
MEDICAL PROPERTIES TRUST, INC.
REPORTS FOURTH QUARTER AND FULL-YEAR 2007 RESULTS
Birmingham, Ala., January 31, 2008 —Medical Properties Trust, Inc. (NYSE: MPW) today announced its operating and other results for the quarter and year ended December 31, 2007.
HIGHLIGHTS
| • | | Posted fourth quarter funds from continuing operations (“FFO”), before one-time items, of $0.30 per diluted share, a 20% increase over the same period in 2006; |
|
| • | | Reported FFO, before one-time items, for the full year 2007 of $1.07 per diluted share, a 16% increase compared to $0.92 per diluted share for 2006; |
|
| • | | Invested approximately $316.0 million in healthcare real estate assets in 2007; |
|
| • | | Reduced exposure to Vibra Healthcare during 2007 to 31% of total revenue from 55% of total revenue in 2006; |
|
| • | | In the fourth quarter, entered into a new $220 million credit facility, which can be increased to $350 million; |
|
| • | | In December 2007, settled forward equity sale agreements and issued 3.0 million shares of common stock for proceeds of $14.43 per share; |
|
| • | | Paid the fourth quarter dividend of $0.27 per common share on January 11, 2008 that was declared on November 16, 2007. |
“MPT had a strong fourth quarter and overall, a terrific 2007 during which we exceeded our investment goals and positioned the company for future growth,” said Edward K. Aldag, Jr., Chairman, President and CEO. “We are enthusiastic about 2008 and we expect to complete at least $200 million in acquisitions this year.
“In the face of some of the worst credit conditions in memory, we successfully completed a larger and less costly syndicated credit facility in the fourth quarter; we are particularly pleased that six leading banks that were not part of our previous facility elected to initiate new relationships with us,” said Aldag. “Our new facility gives us sufficient liquidity to maintain our aggressive growth targets during 2008.”
1
OPERATING RESULTS
For the fourth quarter of 2007, FFO from continuing operations, excluding the previously announced non-cash write-off of loan costs, was $15.0 million, an increase of 50% over the same period in 2006. On a per diluted share basis, FFO from continuing operations was $0.30 for the fourth quarter, an increase of 20% over fourth quarter 2006 FFO per share of $0.25 per diluted share.
Net income for the quarter ended December 31, 2007 was $7.9 million, or $0.16 per diluted share, an increase of 14% compared with net income for the corresponding period in 2006 of $5.6 million, or $0.14 per diluted share.
FFO from continuing operations for the full year 2007 was $51.2 million, an increase of 41% from $36.4 million in 2006. On a per diluted share basis, FFO from continuing operations was $1.07 for 2007, an increase of 16% as compared to $0.92 per diluted share in 2006. (As previously announced, the Company incurred $3.3 million ($0.07 per share) of one-time expense items in the first quarter. These expenses are included in reported FFO from continuing operations.)
Net income for the year ended December 31, 2007 was $41.2 million, or $0.86 per diluted share, an increase of 13% compared with net income for 2006 of $30.2 million or $0.76 per diluted share.
The Company also described the effects of several items that impacted fourth quarter 2007 results.
| • | | As previously announced, the Company incurred a $2.8 million ($0.06) non-cash charge to write off deferred financing costs that were associated with the early termination of the Company’s previous credit facility. |
|
| • | | As previously announced, the Company received a $1.1 million early payment penalty (net of scheduled payments) related to the early payment of a mortgage loan. |
|
| • | | The Company recognized stock compensation expense of approximately $1.2 million in connection with restricted stock awards, even though these shares will not be earned unless certain performance hurdles are achieved in the future. |
Aldag described the recognition of share based compensation expense: “The majority of our share based compensation is derived from share awards that management does not earn unless certain pre-established total shareholder return hurdles are met. This assures our shareholders that most of our executive compensation is only earned after our shareholders have benefited from management’s performance. For example, even though we achieved every business goal that we set at the beginning of 2007, management did not earn any of these performance-based shares because the market value of our common shares declined overall in 2007, along with those of most other REITs. Nonetheless, the accounting rules required us to recognize a compensation expense of almost $1.2 million (or $0.02 per share) even though these shares may never be earned by management.”
2
FUTURE OPERATIONS
Based solely on the Company’s current portfolio, management expects 2008 FFO for in-place assets to approximate $1.21 per diluted share. The in-place FFO run rate is expected to increase based on the amount, timing and terms of acquisitions to be completed during 2008. The estimate could decrease if tenants are unable to pay rent and interest in accordance with the terms of their agreements, if we sell income assets without promptly reinvesting the sales proceeds, if general and administrative costs increase, and possibly if the company sells additional common equity. Interest rate fluctuations on the company’s variable rate debt may also cause the in-place run rate to increase or decrease.
TAX TREATMENT OF 2007 DIVIDENDS
In 2007, the Company declared total dividends of $1.08 per share as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | Total | | | Unrecaptured | | | | | | | |
| | Date | | | Date of | | | Date | | | Allocable | | | Capital | | | Sec. 1250 | | | Return of | | | Allocable | |
Amount | | Declared | | | Record | | | Paid | | | to 2007 | | | Gain | | | Gain | | | Capital | | | to 2008 | |
$0.27 | | November 16, 2006 | | December 14, 2006 | | January 11, 2007 | | $ | 0.077642 | | | $ | 0.192358 | | | $ | 0.085269 | | | | — | | | | — | |
$0.27 | | February 15, 2007 | | March 29, 2007 | | April 12, 2007 | | $ | 0.270000 | | | | — | | | | — | | | | — | | | | — | |
$0.27 | | May 17, 2007 | | June 14, 2007 | | July 12, 2007 | | $ | 0.270000 | | | | — | | | | — | | | | — | | | | — | |
$0.27 | | August 16, 2007 | | September 14, 2007 | | October 19, 2007 | | $ | 0.064352 | | | | — | | | | — | | | $ | 0.205648 | | | | — | |
$0.27 | | November 16, 2007 | | December 13, 2007 | | January 11, 2008 | | | — | | | | — | | | | — | | | | — | | | $ | 0.270000 | |
Of the fourth quarter 2007 dividend that was declared on November 16, 2007, none will be taxable to stockholders as part of their 2007 dividend income and all will be allocable to 2008. Of the third quarter 2007 dividend that was declared on August 16, 2007, $0.064352 will be taxable to stockholders as part of their 2007 dividend income and $0.205648 will be treated as a return of capital. Of the fourth quarter 2006 dividend that was declared on November 16, 2006, $0.077642 will be taxable to stockholders as part of their 2007 dividend income and $0.192358 will be treated as capital gain, with $0.085269 of the total capital gain being unrecaptured Sec. 1250 gain. Accordingly, dividends totaling $0.681994 will be reported as ordinary dividends and $0.192358 will be reported as total capital gain, $0.085269 of which is unrecaptured Sec. 1250 gain, on Form 1099-DIV for 2007. Regarding the dividends included in the 2007 Form 1099-DIV, no amount is considered to be “qualified dividends” (i.e. eligible for the lower individual tax rates).
CONFERENCE CALL AND WEBCAST
The Company has scheduled a conference call and webcast for Thursday, January 31, 2008 at 11:00 a.m. Eastern Time in order to present the Company’s performance and operating results for the quarter and year ended December 31, 2007. The dial-in number for the conference call is 866-510-0707 (U.S.) and 617-597-5376 (International), and the passcode is 18776768. Participants may also access the call via webcast atwww.medicalpropertiestrust.com. A dial-in and webcast replay of the call will be available shortly after completion of the call. Callers may dial (888) 286-8010 (U.S.) or (617) 801-6888 (International), and use passcode 30257183 for the replay.
3
About Medical Properties Trust, Inc.
Medical Properties Trust, Inc. is a Birmingham, Alabama based self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. These facilities include inpatient rehabilitation hospitals, long-term acute care hospitals, regional acute care hospitals, ambulatory surgery centers and other single-discipline healthcare facilities, such as heart hospitals, orthopedic hospitals and cancer centers.
The statements in this press release that are forward looking are based on current expectations and actual results or future events may differ materially. Words such as “expects,” “believes,” “anticipates,” “intends,” “will,” “should” and variations of such words and similar expressions are intended to identify such forward-looking statements, which include statements including, but not limited to, concerning the payment of future dividends, if any, completion of projects under development, acquisition of healthcare real estate, completion of additional debt arrangements, the capacity of the Company’s tenants to meet the terms of their agreements, the level of general and administrative expense, the timing of Vibra’s debt repayment, net income per share and FFO per share in 2007 and FFO in 2008. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those express in or underlying such forward-looking statements, including without limitation: national and economic, business, real estate and other market conditions; the competitive environment in which the Company operations; the execution of the Company’s business plan; financing risks; the Company’s ability to attain and maintain its status as a REIT for federal income tax purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or the healthcare real estate in particular. For further discussion of the facts that could affect outcomes, please refer to the “Risk Factors” section of the Company’sForm 10-K for the year ended December 31, 2006. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this press release.
# # #
4
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
| | | | | | | | |
| | December 31, 2007 | | | December 31, 2006 | |
| | (Unaudited) | | | | | |
Assets | | | | | | | | |
Real estate assets | | | | | | | | |
Land, buildings and improvements and intangible lease assets | | $ | 657,246,917 | | | $ | 437,367,722 | |
Construction in progress | | | 435,110 | | | | 57,432,264 | |
Mortgage loans | | | 185,000,000 | | | | 105,000,000 | |
Real estate held for sale | | | — | | | | 63,324,381 | |
| | | | | | |
Gross investment in real estate assets | | | 842,682,027 | | | | 663,124,367 | |
Accumulated depreciation and amortization | | | (22,490,511 | ) | | | (12,056,422 | ) |
| | | | | | |
Net investment in real estate assets | | | 820,191,516 | | | | 651,067,945 | |
| | | | | | | | |
Cash and cash equivalents | | | 94,215,134 | | | | 4,102,873 | |
Interest and rent receivable | | | 10,325,614 | | | | 11,893,513 | |
Straight-line rent receivable | | | 23,637,435 | | | | 12,686,976 | |
Loans | | | 80,758,273 | | | | 45,172,830 | |
Other assets of discontinued operations | | | 4,354,835 | | | | 6,890,919 | |
Other assets | | | 18,177,879 | | | | 12,941,689 | |
| | | | | | |
Total Assets | | $ | 1,051,660,686 | | | $ | 744,756,745 | |
| | | | | | |
| | | | | | | | |
Liabilities and Stockholders’ Equity | | | | | | | | |
Liabilities | | | | | | | | |
Debt | | $ | 480,525,166 | | | $ | 304,961,898 | |
Debt — real estate held for sale | | | — | | | | 43,165,650 | |
Accounts payable and accrued expenses | | | 21,091,374 | | | | 30,386,858 | |
Deferred revenue | | | 20,839,338 | | | | 14,615,609 | |
Obligations to tenants | | | 16,006,813 | | | | 6,853,759 | |
| | | | | | |
Total liabilities | | | 538,462,691 | | | | 399,983,774 | |
| | | | | | | | |
Minority interests | | | 77,552 | | | | 1,051,835 | |
| | | | | | | | |
Stockholders’ equity | | | | | | | | |
Preferred stock, $0.001 par value. Authorized 10,000,000 shares; no shares outstanding | | | — | | | | — | |
Common stock, $0.001 par value. Authorized 100,000,000 shares; issued and outstanding — 52,133,307 shares at December 31, 2007, and 39,585,510 shares at December 31, 2006 | | | 52,133 | | | | 39,586 | |
Additional paid in capital | | | 540,501,058 | | | | 356,678,018 | |
Distributions in excess of net income | | | (27,170,405 | ) | | | (12,996,468 | ) |
Treasury shares | | | (262,343 | ) | | | — | |
| | | | | | |
Total stockholders’ equity | | | 513,120,443 | | | | 343,721,136 | |
| | | | | | |
Total Liabilities and Stockholders’ Equity | | $ | 1,051,660,686 | | | $ | 744,756,745 | |
| | | | | | |
5
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Statements of Operations
| | | | | | | | | | | | | | | | |
| | For the Three Months Ended | | | For the Twelve Months Ended | |
| | December 31, 2007 | | | December 31, 2006 | | | December 31, 2007 | | | December 31, 2006 | |
| | (Unaudited) | | | (Unaudited) | | | (Unaudited) | | | | | |
Revenues | | | | | | | | | | | | | | | | |
Rent billed | | $ | 17,193,507 | | | $ | 9,654,104 | | | $ | 54,839,688 | | | $ | 32,190,772 | |
Straight-line rent | | | 2,572,708 | | | | 2,265,580 | | | | 11,079,704 | | | | 5,952,442 | |
Interest income from loans | | | 8,192,901 | | | | 3,968,586 | | | | 30,367,971 | | | | 12,328,218 | |
| | | | | | | | | | | | |
Total revenues | | | 27,959,116 | | | | 15,888,270 | | | | 96,287,363 | | | | 50,471,432 | |
Expenses | | | | | | | | | | | | | | | | |
Real estate depreciation and amortization | | | 4,016,710 | | | | 2,195,315 | | | | 12,612,630 | | | | 6,704,924 | |
General and administrative | | | 4,645,463 | | | | 2,335,493 | | | | 15,791,840 | | | | 10,190,850 | |
| | | | | | | | | | | | |
Total operating expenses | | | 8,662,173 | | | | 4,530,808 | | | | 28,404,470 | | | | 16,895,774 | |
| | | | | | | | | | | | |
Operating income | | | 19,296,943 | | | | 11,357,462 | | | | 67,882,893 | | | | 33,575,658 | |
Other income (expense) | | | | | | | | | | | | | | | | |
Interest income | | | 11,446 | | | | 78,049 | | | | 363,558 | | | | 515,038 | |
Interest expense | | | (10,902,615 | ) | | | (3,597,848 | ) | | | (28,236,502 | ) | | | (4,417,955 | ) |
| | | | | | | | | | | | |
Net other income | | | (10,891,169 | ) | | | (3,519,799 | ) | | | (27,872,944 | ) | | | (3,902,917 | ) |
| | | | | | | | | | | | |
Income from continuing operations | | | 8,405,774 | | | | 7,837,663 | | | | 40,009,949 | | | | 29,672,741 | |
Income (loss) from discontinued operations | | | (528,314 | ) | | | (2,244,193 | ) | | | 1,229,690 | | | | 486,957 | |
| | | | | | | | | | | | |
Net income | | $ | 7,877,460 | | | $ | 5,593,470 | | | $ | 41,239,639 | | | $ | 30,159,698 | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Per share amounts — basic and diluted: | | | | | | | | | | | | | | | | |
Income from continuing operations | | $ | 0.17 | | | $ | 0.20 | | | $ | 0.84 | | | $ | 0.75 | |
Income (loss) from discontinued operations | | | (0.01 | ) | | | (0.06 | ) | | | 0.02 | | | | 0.01 | |
| | | | | | | | | | | | |
Net income per share, basic | | $ | 0.16 | | | $ | 0.14 | | | $ | 0.86 | | | $ | 0.76 | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Income from continuing operations | | $ | 0.17 | | | $ | 0.20 | | | $ | 0.84 | | | $ | 0.75 | |
Income (loss) from discontinued operations | | | (0.01 | ) | | | (0.06 | ) | | | 0.02 | | | | 0.01 | |
| | | | | | | | | | | | |
Net income per share, diluted | | $ | 0.16 | | | $ | 0.14 | | | $ | 0.86 | | | $ | 0.76 | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding — basic | | | 49,761,733 | | | | 39,634,127 | | | | 47,717,026 | | | | 39,537,877 | |
Weighted average shares outstanding — diluted | | | 50,069,759 | | | | 39,937,776 | | | | 47,903,432 | | | | 39,701,976 | |
6
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Reconciliation of Net Income to Funds From Operations
(Unaudited)
| | | | | | | | | | | | | | | | |
| | For the Three | | | For the Three | | | For the Twelve | | | For the Twelve | |
| | Months Ended | | | Months Ended | | | Months Ended | | | Months Ended | |
| | December 31, 2007 | | | December 31, 2006 | | | December 31, 2007 | | | December 31, 2006 | |
FFO information | | | | | | | | | | | | | | | | |
Net income | | $ | 7,877,460 | | | $ | 5,593,470 | | | $ | 41,239,639 | | | $ | 30,159,698 | |
Gain on sale | | | — | | | | — | | | | (4,061,626 | ) | | | — | |
Depreciation and amortization | | | 3,794,488 | | | | 2,195,315 | | | | 12,390,408 | | | | 6,704,924 | |
| | | | | | | | | | | | |
Funds from operations | | | 11,671,948 | | | | 7,788,785 | | | | 49,568,421 | | | | 36,864,622 | |
Non-cash write off of loan costs | | | 2,827,023 | | | | — | | | | 2,827,023 | | | | — | |
(Income) loss from discontinued operations | | | 528,313 | | | | 2,244,193 | | | | (1,229,690 | ) | | | (486,957 | ) |
| | | | | | | | | | | | |
Funds from continuing operations | | $ | 15,027,284 | | | $ | 10,032,978 | | | $ | 51,165,754 | | | $ | 36,377,665 | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Per diluted share data: | | | | | | | | | | | | | | | | |
Net income per share, basic and diluted | | $ | 0.16 | | | $ | 0.14 | | | $ | 0.86 | | | $ | 0.76 | |
Gain on sale | | | — | | | | — | | | | (0.09 | ) | | | — | |
Depreciation and amortization | | | 0.07 | | | | 0.06 | | | | 0.26 | | | | 0.17 | |
| | | | | | | | | | | | |
Funds from operations | | | 0.23 | | | | 0.20 | | | | 1.03 | | | | 0.93 | |
Non-cash write off of loan costs | | | 0.06 | | | | — | | | | 0.06 | | | | — | |
(Income) loss from discontinued operations | | | 0.01 | | | | 0.05 | | | | (0.02 | ) | | | (0.01 | ) |
| | | | | | | | | | | | | | |
Funds from continuing operations | | $ | 0.30 | | | $ | 0.25 | | | $ | 1.07 | | | $ | 0.92 | |
| | | | | | | | | | | | |
Funds from operations, or FFO, represents net income (computed in accordance with GAAP), excluding gains (or losses) from sales of property, plus real estate related depreciation and amortization (excluding amortization of loan origination costs) and after adjustments for unconsolidated partnerships and joint ventures. Management considers funds from operations a useful additional measure of performance for an equity REIT because it facilitates an understanding of the operating performance of our properties without giving effect to real estate depreciation and amortization, which assumes that the value of real estate assets diminishes predictably over time. Since real estate values have historically risen or fallen with market conditions, we believe that funds from operations provides a meaningful supplemental indication of our performance. We compute funds from operations in accordance with standards established by the Board of Governors of the National Association of Real Estate Investment Trusts, or NAREIT, in its March 1995 White Paper (as amended in November 1999 and April 2002), which may differ from the methodology for calculating funds from operations utilized by other equity REITs and, accordingly, may not be comparable to such other REITs. FFO does not represent amounts available for management’s discretionary use because of needed capital replacement or expansion, debt service obligations, or other commitments and uncertainties, nor is it indicative of funds available to fund our cash needs, including our ability to make distributions. Funds from operations should not be considered as an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.
7